I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 9 studies | 19% ± 4% | |
| endothelial cell | 6 studies | 22% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 18% ± 2% | |
| non-classical monocyte | 4 studies | 26% ± 7% | |
| classical monocyte | 4 studies | 24% ± 7% | |
| epithelial cell | 4 studies | 35% ± 13% | |
| fibroblast | 4 studies | 24% ± 9% | |
| regulatory T cell | 4 studies | 17% ± 1% | |
| conventional dendritic cell | 3 studies | 32% ± 7% | |
| hematopoietic precursor cell | 3 studies | 19% ± 2% | |
| B cell | 3 studies | 24% ± 7% | |
| ciliated cell | 3 studies | 24% ± 2% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
| macrophage | 3 studies | 21% ± 5% | |
| dendritic cell | 3 studies | 33% ± 9% |
